Quality of Life in SMA Patients Under Treatment With Nusinersen

Background: Spinal Muscular Atrophy (SMA) is a severe neurodegenerative disease, characterized by progressive muscle weakness and atrophy. The approval of the antisense oligonucleotide (ASO) nusinersen now provides an effective pharmacological approach with the potential to slow down or stop disease...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Front Neurol
Hoofdauteurs: Mix, Lucas, Winter, Benedikt, Wurster, Claudia D., Platen, Sophia, Witzel, Simon, Uzelac, Zeljko, Graf, Heiko, Ludolph, Albert C., Lulé, Dorothée
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2021
Onderwerpen:
Neurology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8039289/
https://ncbi.nlm.nih.gov/pubmed/33854472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2021.626787
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items